Aspire Biopharma Holdings, Inc.

Aspire Biopharma Holdings, Inc. is a biopharmaceutical company focused on developing and marketing sublingual delivery technologies for drugs, nutraceuticals, and supplements. Its platform is designed to improve how active ingredients are absorbed by bypassing the gastrointestinal tract, with applications centered on faster onset and more precise administration. The company’s current portfolio includes soluble and fast-acting formulations, such as aspirin-based products for cardiology emergencies and pain management, along with other development programs spanning wellness and specialty therapeutic categories. Aspire Biopharma Holdings, Inc. operates at the intersection of pharmaceuticals and drug-delivery innovation, serving markets that value rapid absorption, dosage control, and alternative delivery formats for established compounds.